` FLB (Fluidigm Corp) vs DAX Index Comparison - Alpha Spread

F
FLB
vs
D
DAX Index

Over the past 12 months, FLB has underperformed DAX Index, delivering a return of -33% compared to the DAX Index's +32% growth.

Stocks Performance
FLB vs DAX Index

Loading
FLB
DAX Index
Add Stock
www.alphaspread.com

Performance Gap
FLB vs DAX Index

Loading
FLB
DAX Index
Difference
www.alphaspread.com

Performance By Year
FLB vs DAX Index

Loading
FLB
DAX Index
Add Stock

Competitors Performance
Fluidigm Corp vs Peers

DAX Index
FLB
0KHE
TMO
DHR
207940
Add Stock

Fluidigm Corp
Glance View

Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.

FLB Intrinsic Value
0.59 EUR
Overvaluation 43%
Intrinsic Value
Price
F
Back to Top